Clinical potential of C-reactive protein and procalcitonin serum concentrations to guide differential diagnosis and clinical management of pneumococcal and Legionella pneumonia
- PMID: 20220163
- PMCID: PMC2863928
- DOI: 10.1128/JCM.01348-09
Clinical potential of C-reactive protein and procalcitonin serum concentrations to guide differential diagnosis and clinical management of pneumococcal and Legionella pneumonia
Abstract
We retrospectively analyzed the records of 61 hospitalized patients with community-acquired pneumonia (CAP) caused by Streptococcus pneumoniae or Legionella pneumophila. We found that serum procalcitonin and sodium concentrations were significantly lower, and ferritin levels were significantly higher, in patients infected with L. pneumophila than in those infected with S. pneumoniae. The ratio of C-reactive protein to procalcitonin significantly distinguished between the groups. High procalcitonin levels were associated with an adverse clinical course.
Figures
References
-
- Bartlett, J. G. 2008. Is activity against “atypical” pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy. Clin. Infect. Dis. 47(Suppl. 3):S232-S236. - PubMed
-
- Christ-Crain, M., D. Stolz, R. Bingisser, C. Mueller, D. Miedinger, P. R. Huber, W. Zimmerli, S. Harbarth, M. Tamm, and B. Mueller. 2006. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am. J. Respir. Crit. Care Med. 174:84-93. - PubMed
-
- Cianciotto, N. P. 2007. Iron acquisition by Legionella pneumophila. Biometals 20:323-331. - PubMed
-
- Diederen, B. M. 2008. Legionella spp. and Legionnaires' disease. J. Infect. 56:1-12. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
